PIM
ATYR

Perkins Investment Management’s aTyr Pharma ATYR Stock Holding History

Perkins Investment Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$56K Buy
+1,143
New +$52.2K ﹤0.01% 248

Other funds holding ATYR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GHCM
Glen Harbor Capital Management San Diego, California $4.82B AUM 4.69% 1-Year Est. Return
MCIM
Meadow Creek Investment Management Atlanta, Georgia $5.09B AUM 5.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Perkins Investment Management's ATYR Position: Q1 2017 in Review

Perkins Investment Management opened a new position in aTyr Pharma (ATYR) in Q1 2017: 1,143 shares worth $56K. The stake represents ﹤0.01% of the portfolio and ranks #248 among its holdings.

39 funds tracked by Wall St. Rank hold ATYR as of Q1 2017.

  • Perkins Investment Management held 1,143 shares of aTyr Pharma worth $56K as of Q1 2017.
  • aTyr Pharma was a new Perkins Investment Management position in Q1 2017.
  • aTyr Pharma made up ﹤0.01% of Perkins Investment Management's portfolio in Q1 2017, its #248 holding.
  • 39 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2017.

Based on Perkins Investment Management's 13F filing for Q1 2017, filed 15 May 2017.